Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma? by Sevilla, Deborah W. et al.
Original Research Article
Cytogenetic abnormalities in reactive lymphoid
hyperplasia: byproducts of the germinal centre reaction
or indicators of lymphoma?y
Deborah W. Sevilla, Vundavalli V. Murty, Xin-Lai Sun, Subhadra V. Nandula, Mahesh M. Mansukhani,
Bachir Alobeid and Govind Bhagat*
Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
*Correspondence to:
Govind Bhagat, Department of
Pathology and Cell Biology, College
of Physicians and Surgeons,
Columbia University, VC14-228,
630 W 168th street, New York,
NY 10032, USA.
E-mail: gb96@columbia.edu
yConflict of interest: the authors
have neither conflict of interest nor
sources of support to declare.
Abstract
Non-random karyotypic abnormalities associated with non-Hodgkin lymphomas (NHLs)
have been described in cases of reactive lymphoid hyperplasia (RLH). However, the
frequency and types of cytogenetic aberrations detected and their clinical relevance
are unknown. To address these questions, we undertook a retrospective analysis of a
large series of RLH diagnosed at our institute over 8 years. Cytogenetic abnormalities were
identified in 20 of 116 (17%) cases with informative karyotypes, comprising 14 (70%)
structural and 11 (55%) numerical changes. Clonal (n¼ 14, 70%) and non-clonal (n¼ 6,
30%) abnormalities were observed. Aberrations of chromosome 14 were the most frequent
(n¼ 8, 42%, 7 represented IgH translocations), followed by chromosome 3 (n¼ 4, 3
represented BCL6 translocations), and chromosome 12 (n¼ 4). Abnormal karyotypes
were most often associated with florid follicular hyperplasia. Isolated lymphoid organ
(lymph node, tonsil or spleen) enlargement (12/20, 60%) was more common, no specific
etiology was identified in 10/20 (50%) cases and only 1 of 18 patients with clinical follow-up
(range 2–107months, median 60months) developed lymphoma. In our experience, cyto-
genetic abnormalities involving loci associated with B-cell NHL are not infrequently
detected in RLH. Their occurrence portends low risk for lymphomagenesis, however
longer follow-up is prudent to further evaluate the natural history of such cases. Copyright
# 2010 John Wiley & Sons, Ltd.
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Introduction
It is well established that reactive clonal proliferations of
B- and T-cells occur in response to antigenic stimulation
[1,2] and such lymphocytic expansions can be detected in
the peripheral blood of older individuals [3,4]. In healthy
individuals, however, reactive clonal B-cell expansions,
which are usually restricted to the germinal centres (GCs)
of lymphoid organs [5], have been demonstrated in lymph
nodes (LN), spleen and acquired lymphoid tissue by
analyzing surface immunoglobulin light chain expression
[6], in peripheral blood by flow cytometry [7] and by
polymerase chain reaction (PCR) [8] or Southern blot
analyses for immunoglobulin heavy chain (IGH) gene
rearrangement in tissue samples [9]. The ability to detect
clonal lymphoid proliferations only in a few instances of
reactive lymphoid hyperplasia (RLH) could reflect reduced
sensitivity of the diagnostic methods utilized or be
indicative of the oligoclonal nature of immune responses
in the majority of cases.
Numerous recurrent and clonal cytogenetic abnormal-
ities described in B- and T-cell non-Hodgkin lymphoma
(NHL) subsets are considered the ‘gold standard’ for
diagnosing specific entities [10]. However, by using
sensitive methods, ‘NHL associated translocations’,
especially IGH/BCL2 [11,12], IGH/BCL6 [13], NPM/
ALK and ATIC/ALK [14] can be detected in LN or
peripheral blood of healthy individuals. Although, the
developmental stage or time of acquisition of t(14;18) is
still debated, the currently favoured view is that it results
from abnormalities of VDJ recombination in bone marrow
B-cell precursors [12]. The increased frequency of t(14;18)
detection in older individuals [15] and HIV or HCV
infected patients [16,17], could thus reflect increased
genotoxic stress due to chronic antigenic stimulation and/
or deregulated immune surveillance allowing persistence
of aberrant clones.
A few studies have investigated DNA ploidy alterations
in RLH [18], but data regarding karyotypic abnormalities
are scarce. Only a few small series and single case reports
have described clonal or non-clonal cytogenetic abnorm-
alities in LN from healthy individuals or patients with non-
neoplastic diseases [18–24]. We, thus retrospectively
analysed a large series of RLH cases to determine the
frequency and types of karyotypic abnormalities detected
and sought correlations between the occurrence of
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chromosomal abnormalities and specific morphologic
patterns of RLH, results of PCR analysis for IGH and
T-cell receptor-g (TCR-g) gene rearrangements and flow
cytometry, and clinical outcomes.
Materials and methods
Case selection and clinical characteristics
We searched our departmental cancer cytogenetics
database to identify all lymphoid organ specimens
submitted for karyotype analysis, irrespective of diagnosis,
over a period of 8 years (1997–2004). Morphologic
features were evaluated by reviewing H&E stained
sections of formalin-fixed, paraffin-embedded tissue. Data
regarding patient demographics, immune status and
clinical outcomes (until November 2009) were obtained
from our laboratory information system. This study was
approved by our institutional review board.
Immunohistochemistry and in situ hybridization
A comprehensive panel of immunohistochemical stains
was performed, which included the following primary
antibodies: CD20, CD3, CD21, BCL2, BCL6, CD43
(DAKO, Carpinteria, CA) and kappa and lambda (Cell
Marque, Hot Springs, AR), after heat-induced antigen
retrieval and visualized with Envision plus (DAKO) and
DAB. In situ hybridization for EBV-encoded small RNAs
(EBER) was performed using the supplied protocol
(INFORM EBER, Ventana, Tuscon, AZ).
Flow cytometry
Three or four-colour flow cytometric analysis was
performed on lymphoid tissue suspensions using FACS-
Calibur (BD Bioscience, San Jose, CA) and data analysed
using the CellQuest software (BD Bioscience), according
to standard methods. The panel of antibodies included
CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD19, CD20,
CD22, CD23, CD16þ 56, CD43, CD79a, kappa and
lambda (BD Bioscience).
Giemsa-banded karyotype and fluorescence
in situ hybridization (FISH) analysis
Giemsa (G)-banding was performed on metaphase
preparations obtained after short-term (12 h) unstimulated
cultures of samples using standard methods. Karyotypes
were described according to the International System for
Human Cytogenetic Nomenclature [25]. FISH analysis
was performed on methanol-acetic acid fixed cells (eight
cases) and paraffin-embedded tissue (four cases) using
IGH (n¼ 6) and BCL6 (3q27) (n¼ 3) dual colour break-
apart (VYSIS, Downers Grove, IL, USA) or centromeric
16 (one case) (Abbott Molecular, Abbott Park, IL, USA)
probes according to standard protocols; 200–500 cells
were analysed and fluorescence signals were captured after
counterstaining with DAPI using the Cytovision Imaging
system attached to a Nikon Eclipse 600 microscope
(Applied Imaging, Santa Clara, CA).
PCR for IGH and TCR-g gene rearrangement
DNA was extracted from paraffin-embedded tissue using
standard methods, briefly five 10m tissue sections were de-
paraffinized with xylene, washed with ethanol and passed
through DNA extraction columns (QIAamp DNA mini kit,
Qiagen, Valencia, CA) using the supplied protocol. PCR
for IGH and TCR-g gene rearrangement, followed by
heteroduplex analysis and polyacrylamide gel electropho-
resis, was performed as previously reported [26,27].
Statistical analysis
Statistical significance of the difference between groups
was calculated using Fisher’s exact test and a p value
<0.05 was considered significant.
Results
Case selection and clinical characteristics
Cytogenetic analysis was performed on 405 consecutive,
unselected, biopsies or resections of enlarged LNs
(n¼ 375), tonsils (n¼ 22) and spleens (n¼ 8) submitted
to our department over the study period, which included
149 cases (130 LN, 16 tonsils and 3 spleens) of RLH and
256 cases (245 LN, 6 tonsils and 5 spleens) of lymphoma.
Successful karyotypes were obtained at a similar frequency
for RLH (78.9%) and lymphoma (80.2%). Two of
149 cases previously diagnosed as RLH were excluded
after histologic review, as one represented nodular
lymphocyte-predominant Hodgkin lymphoma with rare
‘popcorn’ cells and one LN was from a patient with
concurrent T-cell lymphoma in an adjacent node. In the
remaining 147 RLH cases (from 139 patients), abnormal
karyotypes were observed in 20 (13.6%) and normal
karyotypes in 96 (65.3%) cases; karyotype failures
accounted for 31 (21.1%) cases. Overall, chromosomal
abnormalities were detected in 20/116 (17.2%) specimens
(16LN, 2 tonsils and2 spleens)with informativekaryotypes
and a non-neoplastic diagnosis. The demographic and
clinical information of patients in these three groups is
summarized in Table 1.
The majority of patients (12/20, 60%) had isolated
lymphoid organ enlargement, while 8/20 (40%) presented
with generalized lymphadenopathy. Five patients with
karyotypic abnormalities had additional, prior and/or
subsequent, biopsies (time from index case 1–51months)
and karyotypic abnormalities were detected in one of four
cases evaluated (case 11, Table 2); two had normal
karyotypes and one was a karyotypic failure. No etiology
for RLH could be determined in 10/20 (50%) cases; three
patients were HIVþ, two were liver allograft recipients,
one had SLE and four had other immune/autoimmune
disorders. Follow-up information was available for 18/20
cases (range 2–107months, median 60months, mean
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53.3months). Only one patient, a liver allograft recipient,
developed an EBV-associated polymorphic post-transplant
lymphoproliferative disorder (PTLD) after 8months (case
11, Table 2).
Cytogenetic abnormalities detected in RLH
Clonal abnormalities were observed in 14/20 cases with
abnormal karyotypes; seven had minor clones (2–4 cells)
and seven had a higher frequency of aberrant clones (Table
2), while six cases had non-clonal abnormalities (Table 3).
Structural abnormalities included balanced reciprocal
translocations (n¼ 11), inversions (n¼ 3), deletions
(n¼ 2), addition (n¼ 1), isochromosome (n¼ 1), deriva-
tive chromosomes (n¼ 4) and marker chromosomes
(n¼ 3) (Tables 2 and 3). The affected chromosomes were:
chromosome 14 (n¼ 8, 40%, 7 involving the 14q32/IgH
locus), chromosome 12 (n¼ 4), chromosome 3 (n¼ 4,
including 3 with 3q27 rearrangements), chromosome 1
(n¼ 3), chromosome X (n¼ 3), chromosomes 8, 10, 11,
13, 16 and 22 (n¼ 2 each) and chromosomes 2, 5, 6, 9 and
18 (18q21) (n¼ 1 each). In three cases, clonal karyotypic
abnormalities were present in all cells analysed (cases 12–
14, Table 2), suggesting constitutional chromosomal
abnormalities, however, this was not further investigated.
Confirmation by FISH analysis
FISH analysis was performed on metaphase spreads in
eight cases to confirm karyotypic aberrations. IGH break-
apart probes confirmed IGH rearrangements in two cases
(cases 1 and 2, Table 2) with clonal karyotypic
abnormalities (Figure 1A and B), but not in the case with
a non-clonal 14q32 translocation (case 5, Table 3), as it was
below the threshold for detection. BCL6 rearrangement
was confirmed in 1 case (case 3, Table 2) with clonal 3q27
translocation, but not in one case with a non-clonal
translocation (case 3, Table 3), again, since the aberration
was below the detection threshold of the FISH assay.
Trisomy 16 was confirmed by FISH in the single case with
this abnormality (case 4, Table 2, Figure 1C).
FISH analysis for IGH (cases 1 and 2, Table 2) or BCL6
(cases 3 and 5, Table 2) was also performed on paraffin-
embedded sections (interphase cells), after microdissecting
GC using an 18 gauge needle, to determine the
compartment harbouring cells with abnormal karyotypes.
Abnormal FISH signals were localized to the GC in 2, 31
and 37% of cells in cases 1, 3 and 5, respectively but the
results were non-informative for case 2.
Histologic patterns associated with abnormal
karyotypes
Follicular hyperplasia, defined as >90% of lymphoid
follicles displaying reactive GC, for this study, was the
most frequently encountered pattern (n¼ 19). In 13 of
these cases, a variable proportion of follicles showed florid
follicular hyperplasia (FFH) (<30% n¼ 2, 30–60% n¼ 4
and >60% n¼ 7) (representative examples are shown in
Figure 1A and B). Cases of FFH exhibited markedly
expanded GC (CD10þ/BCL6þ/BCL2#), with tingible
body macrophages, attenuated mantle zones and expanded
CD21þ follicular dendritic cell (FDC) meshworks. Eleven
cases demonstrated some degree of folliculolysis with or
without hemorrhage. Eight cases showed focal progressive
transformation of germinal centres (PTGC) or PTGC-like
changes (enlarged follicles with invaginations or tongue
like infiltrates of mantle zone lymphocytes and T-cells into
GC), all of these cases also had FFH. Only mild
paracortical hyperplasia (n¼ 15), including nodular para-
cortical hyperplasia (n¼ 10), was observed. Less frequent
morphologic features of cases with abnormal karyotypes
included, marginal zone/monocytoid lymphocyte hyper-
plasia (n¼ 6), sinus histiocytosis (n¼ 4), paracortical
microgranulomas (n¼ 1) and plasma cell variant of
Castleman’s disease (n¼ 1).
The various histologic patterns observed in the three
groups (abnormal, normal and failure karyotype) are
summarized in Table 4. Of note, although FFH and PTGC
and/or folliculolysis were seen in the majority of cases with
abnormal karyotypes, six cases only showed morphologic
changes encountered in routine cases of reactive follicular
hyperplasia (Tables 2 and 3). Only two cases (cases 3 and
4, Table 2, Figure 1C) warranted the designation of
‘atypical lymphoid hyperplasia’. Due to a lack of
established criteria, it is unclear whether these cases
represent the non-IGH/BCL2 counterparts of the IGH/
BCL2 translocation-associated situ follicular lymphoma
[28], since it is known that non-IGH/BCL2 follicular
lymphomas can lack BCL2 expression [29].
Table 1. Clinical information of 147 RLH cases evaluated
Case/patient characteristics Karyotype
Abnormal Normal Failure
Number of cases 20 96 31
Age (median) 2–82 years (43) 0.5–88 years (38) 2–72 years (41)
Sex (M/F) 7/13 46/50 15/16
Lymph nodes (%) 16 (80) 84 (88) 28 (90)
Tonsils (%) 2 (10) 12 (13) 2 (7)
Spleen (%) 2 (10) 0 1 (3)
HIV (%) 3 (15) 10 (10) 5 (16)
S/P Solid organ transplant (%) 2 (10) 6 (6) 4 (13)
SLE (%) 1 (5) 2 (2) 0
Generalized lymphadenopathy (%) 8 (40) 5 (5) 1 (3)
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Cytogenetic abnormalities were significantly more
frequently observed in cases presenting with generalized,
compared to, isolated lymphadenopathy (8/14, 57% vs. 12/
133, 9%, p¼ 0.00005). Overall, abnormal karyotypes were
noted in 13/39 (33.3%) cases of FFH with informative
karyotypes. Statistically significant differences were noted
with regard to the presence of follicular hyperplasia
(p¼ 0.023), FFH (p¼ 0.0003) and PTGC-like changes
(p¼ 0.003) in cases with abnormal karyotype compared to
those with normal karyotype and karyotypic failures
combined; significance was maintained even after remov-
ing the three cases with putative constitutional abnorm-
alities from analysis. The triad of FFH, folliculolysis and
focal PTGC was also more commonly seen in cases with
karyotypic aberrations (p< 0.01). Comparisons between
cases with abnormal karyotypes and those with normal
karyotypes and karyotypic failures, individually, are listed
in Table 4.
Immunohistochemistry and in situ hybridization
Immunohistochemical staining did not detect BCL2 or
CD43 expression in GC B-cells in all cases. On staining for
kappa and lambda light chains, a monotypic plasma cell
population was only observed in the case of HHV-8
associated Castleman’s disease, which had the character-
istic lambdaþ plasma cells restricted to the follicles. In
situ hybridization for EBER was performed in all 20 cases.
Only scattered EBERþ cells (<5%) were present in 2/6
cases with non-clonal karyotypic abnormalities, including
Figure 1. Morphologic features of representative cases of reactive lymphoid hyperplasia with clonal cytogenetic abnormalities, H&E
stained sections (left), corresponding immunohistochemical stains (middle) and G-band/FISH findings (right). (A) Case 1, Table 2:
cervical LN with FFH and focal folliculolysis. Karyotype analysis demonstrated 46,XY,der(14)t(14;?;12)(q32;?;q13)[3/21]. FISH analysis
using IGH break-apart probes confirmed 14q32 rearrangement of one copy (separate red and green signals) and one normal (fused
yellow) signal. Inset shows partial karyotype of aberrant chromosomes 12 and 14. (B) Case 2, Table 2: cervical LN with FFH and focal
folliculolysis. Karyotype analysis yielded 46,XX,t(12;14)(q11.2;q32)[5/20]. FISH analysis using IGH break-apart probes confirmed
rearrangement of one copy of IGH (green and red signal separation). A single yellow (fusion) signal representing the normal allele is
present on the normal chromosome 14. Inset shows partial karyotype of chromosomes 12 and 14. (C) Case 4, Table 2: supraclavicular
LN exhibiting FFH and PTGCs. Clonal karyotypic abnormalities found in this cases were 47,X, add(X)(p22.1), þ16[2/20]. Interphase
FISH performed with a CEP16 probe shows three copies of chromosome 16 (red signals). Inset shows a partial karyotype comprising
three copies of chromosome 16. (D) Case 5, Table 2: splenic white pulp with FFH andmild marginal zone hyperplasia. G-band karyotype
showed 46,XX,t(3;22)(q27;q11)[7/20]. Partial karyotype shows abnormal chromosomes 3 and 22 displaying t(3;22)(q27;q11)
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a LN from an HIVþ patient, and 4/14 of cases with clonal
karyotypic abnormalities, including LN from two HIVþ
patients. All except one post-liver transplant FFH (case 11,
Table 2), described previously [30], were deemed to be
EBV negative lymphoproliferations.
Immune receptor gene rearrangement and flow
cytometry
PCR analysis for IGH and TCR-g genes was undertaken
for all 20 cases with abnormal karyotypes and a subset of
cases with normal karyotypes (IGH, n¼ 25 and TCR-g ,
n¼ 21) and karyotypic failures (IGH, n¼ 13 and TCR-g ,
n¼ 12). Cases with normal or failed karyotypes submitted
for PCR analysis had histologic patterns similar to the
abnormal karyotype group. Of the evaluated cases, three
cases with abnormal karyotypes (Tables 2 and 3) and one
case each with normal karyotype and karyotype failure
showed clonal products on IGH gene rearrangement
analysis, while two cases with abnormal karyotypes
(Tables 2 and 3), one case with a normal karyotype, and
none of the karyotype failure cases showed clonal products
on TCR-g gene rearrangement analysis. There was no
significant difference in the frequency of detecting a clonal
IGH or TCR-g rearrangement between the three groups.
No correlation between the presence of a clonal product
and frequency of abnormal metaphases was observed.
Flow cytometry was performed on all 20 cases with
abnormal karyotypes, 82/96 (85.4%) cases with normal
karyotypes, and 28/31 (90.3%) cases with failed karyo-
types. No monotypic (clonal) B or aberrant T-cell
populations were detected in any case (kappa:lambda—
range 0.9–2.4:1 for cases with an abnormal karyotype).
Discussion
We report a spectrum of chromosomal abnormalities in
17% of RLH with successful G-band karyotypes, which
were detected on analyzing the largest series of cases
described to date in an unbiased manner. Both clonal and
non-clonal changes and structural as well as numerical
aberrations were identified. Follicular hyperplasia, often
accompanied by FFH, was the most frequent morphologic
correlate of cases harbouring cytogenetic abnormalities,
but other structural alterations of the GC, for example
PTGC-like changes or folliculolysis were not infrequent.
Phenotypic aberrations were not observed in any case. The
majority of patients had localized lymphadenopathy,
however the frequency of karyotypic abnormalities was
significantly higher in those presenting with generalized
lymphadenopathy. None had evidence of lymphoma at
presentation, despite the detection of aberrations that are
known recurrent abnormalities in B-NHL.
Karyotypic abnormalities of chromosome 14 were the
most frequent (40% of our cases), the majority represent-
ing translocations involving the IGH locus (band 14q32).
IGH rearrangements are not unique to any entity and are
seen in a wide variety of lymphomas. Similarly,
rearrangements of BCL6 (3q27), seen in 20% of our
cases, have also been described in follicular lymphoma,
DLBCL, nodular lymphocyte predominant Hodgkin
lymphoma, and rarely other types of B-NHL [10]. Other
aberrations (1q, 22q11 and 12q), though less frequently
observed, have also been documented in different B-NHL
[31–33]. A notable exception in our series was a failure to
detect t(14;18). It is unclear if this reflects the relative
insensitivity of G-band analysis compared to PCR analysis,
since the published literature is based on the latter
detection method [11]. A low proliferation rate of rare non-
neoplastic cells harbouring this translocation might not
allow detection on analysis of metaphase preparations.
Karyotypic abnormalities have been reported in 30–45%
of RLH cases in prior, smaller, studies of healthy
individuals [18,20]. The types of chromosomes affected
and kinds of abnormalities described in some differ from
ours. Grace et al. [18] reported 20 cases of RLH and unlike
our study, detected frequent chromosome 9 and 22 (20%)
aberrations, as well as del 8q and del 3q, also known NHL-
associated changes [10]. Chromosome 14 abnormalities
were found in only two cases, but no IGH translocations
were identified. Clinical data or results of clonality
Table 4. Histopathologic features of RLH cases







Follicular hyperplasia (%) 19 (95)a 68 (71) 0.0432 7 (23) 0.0003
Florid follicular hyperplasia (%) 13 (65)b 26 (27) 0.0018 3 (10) <0.0001
PTGC (%) 8 (40)c 12 (13) 0.0068 0 0.0002
Folliculolysis 11 (55)d 33 (34) 0.1270 2 (7) 0.0002
Nodular paracortical hyperplasia (%) 10 (50)e 50 (52) 1 16 (52) 1
Granulomas (%) 1 (5)f 13 (14) 0.4585 9 (29) 0.0673
The p values in the columns correspond to differences between cases with abnormal karyotypes and those with either normal
karyotypes or karyotypic failures. The p values for comparisons between cases with abnormal karyotypes and normal and failed
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assessment were not provided. A recent report by Au
et al. [20] described 30 cases of apparent RLH with
10 cases demonstrating clonal and 3 cases non-clonal
karyotypic abnormalities. Slightly more frequent trans-
locations involving IGH (54%) and BCL6 (46%) loci
were described in this study compared to ours, as
were cases with t(14;18)(q32;q21), t(11;14)(q13;q32)
and t(3;14)(q27;q32). Interestingly, clonal IGH gene
rearrangement products by PCR were detected at a much
higher frequency (50% of cases with abnormal karyotypes,
including one case with a non-clonal karyotypic aberra-
tion) than our study. Despite detecting similar cytogenetic
abnormalities, only one of our patients developed
lymphoma, compared to concurrent or subsequent NHL
observed in all 10 cases with clonal karyotypic abnorm-
alities in the series of Au et al. [20]. That said, the
median duration of follow-up of our cases (5 years) is
insufficient to determine if, and how many of, the RLH
cases could progress to low grade lymphomas. This
question can only be answered by significantly longer
follow-up evaluation.
Case reports of RLH with abnormal karyotypes have
also been published, but follow-up information was
lacking in all. Chenevix-Trench et al. [21] described
t(2;19) (p11.2;19q13) in a case of atypical lymphoid
hyperplasia. Alterations of the transforming growth factor
alpha or beta genes that map to 2p11-p13 and 19q13,
respectively, or the kappa locus (2p11-p12) were not
detected by Southern blot. Zhang et al. [24] described a
case of persistent, isolated inguinal LN enlargement
demonstrating follicular hyperplasia, sinus histiocytosis
and clusters of epithelioid cells with 46,XY,del(8)(p11),
der(14)t(8;14)(p11;q31). No IGH or TCR-g gene re-
arrangement was detected by Southern blot. Similar
to one of our cases, Pinkerton et al. [23] reported
t(1;14)(q21;q32), along with trisomy X, in an enlarged
mandibular LN showing marked follicular and interfolli-
cular hyperplasia. Flow cytometry did not detect a
monotypic B-cell population, but a clonal IGH rearrange-
ment was identified by Southern blot. Translocations or
aberrations of chromosome 1q21, a gene-rich region, are
frequently encountered as secondary alterations in a
variety of lymphomas [32,33] and genes located in
cytoband 1q21-23 have also been implicated in suscepti-
bility to autoimmune diseases [34]. Only a few recurrently
targeted genes have been identified at this locus thus far.
Identification of chromosome 1q aberrations as isolated
abnormalities in RLH suggests the requirement of
additional abnormalities for lymphoma development or
progression.
In our series, non-clonal cytogenetic abnormalities were
seen in 30% of cases. Non-clonal changes are considered
artefacts of tissue culture, mostly stimulated or long-term.
Hence, although all our cases underwent unstimulated
short-term culture, ex vivo occurrence of such changes
cannot be completely ruled out in all cases. The observed
non-clonal changes were varied, but included 14q32 and
3q27 rearrangements and a single case showed inversion
14(q11;q32). Interestingly, the latter aberration has been
described previously as a minor clonal abnormality in NHL
(type unspecified), observed only upon mitogenic (PHA
and IL2) stimulation [35].
The histologic patterns observed have been previously
described in autoimmune diseases, infections (HIV, EBV,
HCV, etc.) and inflammatory disorders [36,37], which are
associated with an increase risk of lymphoma [38]. Immune
deregulation due to altered immunity [39] and immune
senescence [40] are a few hypothesized mechanisms.
Persistent or excessive antigen stimulation or an inability
to limit the humoral or GC response due to acquired or
inherited defects could contribute to the development of
lymphomas. Defects in Fas–Fas ligand interactions are
associated with autoimmune syndromes and Fas mutations
have been reported in lymphomas [41]. Errors in immu-
noglobulin remodelling during the GC reaction have been
implicated in generating chromosomal translocations [42].
Rearrangements of IGH,BCL6 and other oncogenes, aswell
as acquisitionof somaticmutations in thesegenes [43,44] are
believed to play crucial roles in lymphomagenesis [42]. The
fusion transcripts themselves appear insufficient for gen-
erating lymphomas, requiring additional genetic or epige-
netic alterations. Transgenic mice expressing NHL-associ-
ated translocations support this notion. FFH is observed in
many models and lymphomas occurring later harbour
additional genetic alterations [42,45–47]. Yang et al. [13]
recently also described IGH/BCL6 rearrangements inGCB-
cells of healthy humans by PCR-based assays. Our findings
of frequent 14q32 and 3q27 aberrations, localized to the GC
ina fewcases analysed, are supportive of the aforementioned
etiopathogenic concepts. These changes could represent a
‘first hit’, perhaps providing a mild proliferative advantage,
though cells harboring such abnormalities are likely
eliminated by a functional immune system. Faulty immune
surveillance might allow accrual of genetic alterations and
outgrowth of lymphoma, as proposed earlier and observed in
one case [30]. Discovery of polymorphisms in immune
receptor or inflammatory pathway genes or in DNA repair
components could also shedmore light on the relationship of
RLH with B-NHL [48].
The etiology of RLH could not be determined in half of
our cases. An infectious trigger is a possibility for some,
since most of the cases involved superficial LN. Only a
minority of patients were immunosuppressed (HIV
infection and allograft recipients) or had autoimmune
diseases. Interestingly, however these etiologies accounted
for all except one of our eight cases presenting with
generalized lymphadenopathy. Alonso et al. [19] described
chromosomal abnormalities in 3/7 cases of AIDS-
associated lymphadenopathy without histologic evidence
of lymphoma, including one case each of ‘non-specific
chromosome breakage’, hypodiploid karyotype, and
t(8;14)(q24;q32). Two of the patients developed NHL
after an unspecified duration. Offit et al. [22] reported a
t(3;22)(q27;q11), trisomy 7 and inversion/duplication of
chromosome 1 (q44-q31) in HIV-associated atypical
lymphoid hyperplasia, clinical outcome data, however,
were not provided. In our series, BCL6 translocations were
observed in both, immunocompetent and immunosup-
pressed (HIV infection) individuals who had no clinical
evidence of lymphoma. Osborne and Butler described
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concurrent or subsequent (1month–9 years later) lympho-
mas in one-third of 58 patients >60 years with reactive
follicular hyperplasia [49]. Of interest, we also observed a
high frequency of abnormal karyotypes in cases of FFH (1/
3 with this pattern), however only one patient with this
reaction pattern, a liver allograft recipient, subsequently
developed an EBVþ PTLD.
Flow cytometry and PCR analysis of immune receptor
gene rearrangements are useful tools in the diagnostic
work up of NHL. Recent investigations using these
modalities, however have also cautioned against inter-
preting clonal populations alone as evidence of neoplasia.
Kussick et al. [7] described prominent monotypic GC B-
cell populations by flow cytometry in RLH. Clonal IGH
rearrangements were detected by PCR or Southern
blotting, but no BCL2 expression or t(14;18) was observed
(karyotype data were not provided). No individual
developed lymphoma on follow-up of 13–56months.
Intriguingly, monotypic populations were not detected
by flow cytometry in any of our cases. A study by the
BIOMED-2 Concerted Action Committee described clonal
lymphoid populations in 10% of RLH by PCR analysis
[50]. Using different PCR protocols, clonal products were
detected in 25% of our RLH cases with karyotypic
abnormalities (both IGH and TCR-g), but without
significant difference in frequency compared to cases
with normal or failed karyotypes. Importantly, there was no
correlation between detection of clonality by karyotype
and PCR analysis.
In conclusion, we describe a variety of chromosome
abnormalities in RLH, many involving loci associated with
B-NHL. The aberrant clones were often small and not
detectable by flow cytometry or PCR analysis. Although
the frequency of developing NHL was low in our series,
longer-term follow up is required to fully evaluate the
neoplastic potential of such cases.
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